Latest News about MNKD
Recent news which mentions MNKD
Jim Cramer Recommends Selling This Stock: 'No One Ever Likes Me To Say Anything Bad' About This Company
August 04, 2022
From Benzinga
Why Shares of MannKind Corporation Climbed 10.4% on Monday
August 01, 2022
From Motley Fool
Energy stocks are this year’s best performers — but they’re not on the list of top investment newsletters
June 10, 2022
From MarketWatch
From Benzinga
7 Biotech Stocks With Key Catalysts for May
May 11, 2022
From InvestorPlace
Tickers
MNKD
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
March 17, 2022
From Benzinga
3 Market ETF Stocks to Buy This Week on Fed Jitters
March 14, 2022
From InvestorPlace
These are the stocks to own as inflation starts to slow
March 11, 2022
From MarketWatch
68 Biggest Movers From Yesterday
March 03, 2022
From Benzinga
From Benzinga
41 Stocks Moving In Wednesday's Mid-Day Session
March 02, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
February 28, 2022
From Benzinga
93 Biggest Movers From Friday
February 28, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 25, 2022
From Benzinga
45 Stocks Moving In Friday's Mid-Day Session
February 25, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 25, 2022
From Benzinga
88 Biggest Movers From Yesterday
February 25, 2022
From Benzinga
MannKind Corporation (MNKD) Q4 2021 Earnings Call Transcript
February 25, 2022
Tickers
MNKD
From Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
February 24, 2022
From Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
February 24, 2022
From Benzinga
FDA Pushes United Therapeutics-MannKind Tyvaso DPI's Decision Date; United Therapeutics' Q4 Misses Consensus
February 24, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 23, 2022
From Benzinga
Executives Buy Over $2.7M Of 4 Penny Stocks
February 03, 2022
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 28, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
